STATEMENT OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities
Net income (loss)	$ 5,716,045	$ (2,898,231)
Adjustments to reconcile net income (loss) to net cash used in operating activities
Interest earned on marketable securities held in Trust	(43,154)	(3,450)
Offering costs allocated to warrants	0	606,375
Change in fair value of warrant liability	(6,028,098)	2,248,713
Changes in operating assets and liabilities
Prepaid assets	42,684	(673,222)
Due to related party	(2,000)	2,957
Accrued offering costs and expenses	(129,042)	689,000
Net cash used in operating activities	(443,565)	(27,858)
Cash flows from investing activities
Investment of cash in trust account	0	(172,500,000)
Net cash used in investing activities	0	(172,500,000)
Cash flows from financing activities
Proceeds from sale of Units, net of underwriting discount	0	169,050,000
Proceeds from issuance of Private Placement Warrants	0	5,950,000
Repayment of promissory note - related party	0	(176,000)
Proceeds from working capital loan - related party	163,300	0
Payment of offering costs	0	(691,574)
Net cash provided by financing activities	163,300	174,132,426
Net change in cash	(280,265)	1,604,568
Cash, beginning of period	315,594	153,938
Cash, end of the period	35,329	1,758,506
Supplemental disclosure of cash flow information:
Deferred underwriters' discount payable charged to additional paid-in capital	$ 0	$ 6,037,500